SPH7485
/ Shanghai Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 07, 2024
SPH7485-101: A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
(clinicaltrials.gov)
- P1 | N=170 | Recruiting | Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology • Solid Tumor
July 05, 2024
SPH7485-101: A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
(clinicaltrials.gov)
- P1 | N=170 | Not yet recruiting | Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1